Securities Code: 002044
Securities Abbreviation: Meinian Health
Announcement Number: 2026-049
Meinian Health Industry Holding Co., Ltd. (hereinafter referred to as "the Company" or "the Listed Company") and all members of the Board of Directors guarantee that the content of this information disclosure is true, accurate, and complete, without false records, misleading statements, or significant omissions.
On June 1, 2026, the Company held the 24th (temporary) meeting of the 9th Board of Directors to review and approve the proposals regarding the signing of the "Explanation on the Insufficient Subscription of Financial Investment Shares in the Reorganization of Bangjie" and the proposal for the wholly-owned subsidiary to pay a security deposit for the creation of capital reserves. The relevant situation is announced as follows:
I. Background of Progress
According to the announcement issued by Zhejiang Bangjie Holdings Group Co., Ltd. (hereinafter referred to as "Bangjie") on January 6, 2026, regarding the court's decision to initiate pre-reorganization and appoint a temporary administrator (Announcement Number: 2026-001), the Jinhua Intermediate People's Court made the decision on January 5, 2026, to initiate pre-reorganization for Bangjie and appointed Zhejiang Jingheng Law Firm and Beijing JunHe (Hangzhou) Law Firm (hereinafter referred to as "the Temporary Administrator") as the temporary administrators for Bangjie.
On January 8, 2026, the Temporary Administrator publicly recruited reorganization investors in accordance with the provisions of the "Enterprise Bankruptcy Law of the People's Republic of China" and relevant regulations. The specific content can be found in Bangjie's announcement regarding the public recruitment of reorganization investors (Announcement Number: 2026-004).
On January 29, 2026, the Company held the 17th (temporary) meeting of the 9th Board of Directors, where it reviewed and approved the proposal to participate in the pre-reorganization of Zhejiang Bangjie Holdings Group Co., Ltd. The Company agreed to participate as an interested investor in the public recruitment of reorganization investors for Bangjie and designated its wholly-owned subsidiary, Meinian Health Industry (Group) Co., Ltd. (hereinafter referred to as "Meinian Health"), as the reorganization acquirer to gain control of Bangjie and become its controlling shareholder after the reorganization is completed. The Board authorized the management to organize the selection of investors, due diligence, and preparation of the pre-reorganization investment plan.